MRI protocol development for MR-linac

Recruiting

Conditions: Geen specifieke aandoening te benoemen. De ontwikkelde protocollen en beeldverwerkingstechnieken kunnen voor verschillende aandoeningen worden gebruikt.
protocol development
MRI protocol optimization for MR-linac

Registration Number: NL-OMON55710

Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 900

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all
of the following criteria:, - >= 18 years
- Capable and prepared to sign informed consent
- Healthy volunteers or cancer patients who will be or are treated at the
radiotherapy department, or patients with cancer at a stage or at a site that
is not routinely treated with radiotherapy, where the aim is that future
patients with a similar tumor stage or tumor site might be treated on the MRL.

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded
from participation in this study:, - Contraindication for MRI scanning as
listed in screening form
- Neurological or psychiatric diagnosis
- MRI contraindications such as (possible) pregnancy and metal or electronic
implants not compatible with MRI
- Refusal of subjects to be informed of chance findings possibly relevant to
their health
- In case study participation would interfere with regular treatment

Study & Design

Study Type: Observational invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The optimized MRI protocols and processing techniques required for MRI guided<br /><br>radiotherapy on the MR linac measured as signal to noise ratio, contrast, and<br /><br>acquisition time. </p><br>

Secondary Outcome Measures